Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 13:2019:2059516.
doi: 10.1155/2019/2059516. eCollection 2019.

The Prominent Role of HMGA Proteins in the Early Management of Gastrointestinal Cancers

Nathalia Meireles Da Costa  1 , Luis Felipe Ribeiro Pinto  1 , Luiz Eurico Nasciutti  2 , Antonio Palumbo Jr  2
Affiliations
Review

The Prominent Role of HMGA Proteins in the Early Management of Gastrointestinal Cancers

Nathalia Meireles Da Costa et al. Biomed Res Int. .

Abstract

GI tumors represent a heterogeneous group of neoplasms concerning their natural history and molecular alterations harbored. Nevertheless, these tumors share very high incidence and mortality rates worldwide and patients' poor prognosis. Therefore, the identification of specific biomarkers could increase the development of personalized medicine, in order to improve GI cancer management. In this sense, HMGA family members (HMGA1 and HMGA2) comprise an important group of genes involved in the genesis and progression of malignant tumors. Additionally, it has also been reported that HMGA1 and HMGA2 display an important role in the detection and progression of GI tumors. In this way, HMGA family members could be used as reliable biomarkers able to efficiently track not only the tumor per se but also the main risk conditions related with their development of GI cancers in the future. Finally, it shall be a promising option to revert the current scenario, once HMGA genes and proteins could represent a convergence point in the complex landscape of GI tumors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

    1. Runyan A., Banks J., Bruni D. S. Current and future oncology management in the United States. Journal of Managed Care & Specialty Pharmacy. 2019;25(2):272–281. doi: 10.18553/jmcp.2019.25.2.272. - DOI - PMC - PubMed
    1. Pauli C., Hopkins B. D., Prandi D., et al. Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer Discovery. 2017;7(5):462–477. doi: 10.1158/2159-8290.cd-16-1154. - DOI - PMC - PubMed
    1. Fusco A., Fedele M. Roles of HMGA proteins in cancer. Nature Reviews Cancer. 2007;7(12):899–910. doi: 10.1038/nrc2271. - DOI - PubMed
    1. Abe N., Watanabe T., Sugiyama M., et al. Determination of high mobility group I (Y) expression level in colorectal neoplasias: a potential diagnostic marker. Cancer Research. 1999;59(6):1169–1174. - PubMed
    1. Chiappetta G., Manfioletti G., Pentimalli F., et al. High mobility group HMGI (Y) protein expression in human colorectal hyperplastic and neoplastic diseases. International Journal of Cancer. 2001;91(2):147–151. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1033>3.3.co;2-m. - DOI - PubMed

LinkOut - more resources